Bayer Warns of Lower Earnings as Turnaround Continues
Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...
Fierce Pharma9d
As Xarelto's decline picks up speed, Bayer doesn't expect pharma growth until 2027
While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...
Bayer faces investors' impatience ahead of fourth-quarter results
Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...
Bayer expects improved performance from 2026 onwards
The company expects improved performance from 2026 onwards. Alongside its four existing strategic priorities, the company is adding ...
Bayer warns of third straight year of falling profits amid turnaround effort
On an unadjusted basis, the company reported a net loss of €335mn for the fourth quarter of 2024, compared with €1.34bn net profit for the same period in 2023, and a net loss of €2.55bn for 2024, ...